Dr. Reddy’s biosimilar of Roche’s cancer drug gets EMA panel nod
Dr. Reddy’s had previously received EU (Good manufacturing practice) GMP certificate for its Rituximab drug substance and drug product manufacturing facility located in Hyderabad. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending launch of Dr. Reddy’s Laboratories’ proposed biosimilar Rituximab candidate DRL_RI … Read more
